Tapping the RNA world for therapeutics

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Nature Structural & Molecular Biology

• Publication date

  2018-04-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/s41594-018-0054-4PMID 29662218PMCID PMC6052442
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Functional Classification and Experimental Dissection of Long Noncoding RNAs.

  2018cited by this paper
• Tisagenlecleucel in Children and Young Adults with B‐Cell Lymphoblastic Leukemia

  2018cited by this paper
• mRNA vaccines — a new era in vaccinology

  2018cited by this paper
• A modular platform for targeted RNAi therapeutics

  2018cited by this paper
• Gene therapy comes of age

  2018cited by this paper
• CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.

  2017cited by this paper
• Clinical Proof of Concept for a Novel Hepatocyte-Targeting GalNAc-siRNA Conjugate.

  2017cited by this paper
• The Dimensions, Dynamics, and Relevance of the Mammalian Noncoding Transcriptome.

  2017cited by this paper
• Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial.

  2017cited by this paper
• Effect of PCSK9 Inhibitors on Clinical Outcomes in Patients With Hypercholesterolemia: A Meta‐Analysis of 35 Randomized Controlled Trials

  2017cited by this paper
• Pharmacology of Antisense Drugs.

  2017cited by this paper
• Refining strategies to translate genome editing to the clinic

  2017cited by this paper
• Worth the RISC?

  2017cited by this paper
• The chemical evolution of oligonucleotide therapies of clinical utility

  2017cited by this paper
• Axicabtagene Ciloleucel CAR T‐Cell Therapy in Refractory Large B‐Cell Lymphoma

  2017cited by this paper
• Overcoming cellular barriers for RNA therapeutics

  2017cited by this paper
• Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy

  2017cited by this paper
• CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes.

  2017cited by this paper
• Asialoglycoprotein receptor 1 mediates productive uptake of N-acetylgalactosamine-conjugated and unconjugated phosphorothioate antisense oligonucleotides into liver hepatocytes

  2017cited by this paper
• Nucleic Acid Therapies for Cystic Fibrosis

  2017cited by this paper
• Cellular uptake and trafficking of antisense oligonucleotides

  2017cited by this paper
• Zika virus protection by a single low dose nucleoside modified mRNA vaccination

  2017cited by this paper
• Nusinersen versus Sham Control in Infantile‐Onset Spinal Muscular Atrophy

  2017cited by this paper
• An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria.

  2017cited by this paper
• Modified mRNA Vaccines Protect against Zika Virus Infection.

  2017cited by this paper
• RNA-based recognition and targeting: sowing the seeds of specificity

  2017cited by this paper
• Molecular Mechanisms of Antisense Oligonucleotides

  2017cited by this paper
• Safety and efficacy of a TTR specific antisense oligonucleotide in patients with transthyretin amyloid cardiomyopathy

  2017cited by this paper
• A Highly Durable RNAi Therapeutic Inhibitor of PCSK9

  2017cited by this paper
• Docosahexaenoic Acid Conjugation Enhances Distribution and Safety of siRNA upon Local Administration in Mouse Brain

  2016cited by this paper
• In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy

  2016cited by this paper
• In vivo gene editing in dystrophic mouse muscle and muscle stem cells

  2016cited by this paper
• Aptamers as targeted therapeutics: current potential and challenges

  2016cited by this paper
• Embracing proteins: structural themes in aptamer-protein complexes.

  2016cited by this paper
• Nucleic Acid Modifications in Regulation of Gene Expression.

  2016cited by this paper
• Translation efficiency of mRNAs is increased by antisense oligonucleotides targeting upstream open reading frames

  2016cited by this paper
• Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy

  2016cited by this paper
• Advances in RNAi therapeutic delivery to leukocytes using lipid nanoparticles

  2016cited by this paper
• Cornerstones of CRISPR–Cas in drug discovery and therapy

  2016cited by this paper
• Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1

  2016cited by this paper
• Seq and You Will Find.

  2016cited by this paper
• Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics

  2016cited by this paper
• RNA-mediated epigenetic regulation of gene expression

  2015cited by this paper
• Manipulating the in vivo immune response by targeted gene knockdown.

  2015cited by this paper
• Knocking down disease: a progress report on siRNA therapeutics

  2015cited by this paper
• mRNA: Fulfilling the Promise of Gene Therapy.

  2015cited by this paper
• Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies

  2015cited by this paper
• Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown

  2015cited by this paper
• Unique features of long non-coding RNA biogenesis and function

  2015cited by this paper
• Gene Knockdown by EpCAM Aptamer–siRNA Chimeras Suppresses Epithelial Breast Cancers and Their Tumor-Initiating Cells

  2015cited by this paper
• PIWI-Interacting RNA: Its Biogenesis and Functions.

  2015cited by this paper
• siRNA conjugates carrying sequentially assembled trivalent N-acetylgalactosamine linked through nucleosides elicit robust gene silencing in vivo in hepatocytes.

  2015cited by this paper
• Hepatocyte‐Specific Delivery of siRNAs Conjugated to Novel Non‐nucleosidic Trivalent N‐Acetylgalactosamine Elicits Robust Gene Silencing in Vivo

  2015cited by this paper
• The roles of CRISPR-Cas systems in adaptive immunity and beyond.

  2015cited by this paper
• The noncoding RNA revolution-trashing old rules to forge new ones.

  2014cited by this paper
• Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing.

  2014cited by this paper
• Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice

  2014cited by this paper
• Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype

  2014cited by this paper
• Beyond antibodies: New affinity reagents to unlock the proteome

  2014cited by this paper
• RNAi-mediated silencing of hepatic Alas1 effectively prevents and treats the induced acute attacks in acute intermittent porphyria mice

  2014cited by this paper
• Multifunctional aptamer-miRNA conjugates for targeted cancer therapy.

  2014cited by this paper
• Posttranscriptional regulation of gene expression by Piwi proteins and piRNAs.

  2014cited by this paper
• Treatment of HCV infection by targeting microRNA.

  2013cited by this paper
• Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape

  2013cited by this paper
• Current progress on aptamer-targeted oligonucleotide therapeutics.

  2013cited by this paper
• A decade of riboswitches.

  2013cited by this paper
• Riboswitches and the RNA world.

  2012cited by this paper
• RNA therapeutics: beyond RNA interference and antisense oligonucleotides

  2012cited by this paper
• Roles for microRNAs in conferring robustness to biological processes.

  2012cited by this paper
• Advances in human proteomics at high scale with the SOMAscan proteomics platform.

  2012cited by this paper
• Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

  2011cited by this paper
• CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III

  2011cited by this paper
• Structure-based druggability assessment--identifying suitable targets for small molecule therapeutics.

  2011cited by this paper
• Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

  2010cited by this paper
• Desperately seeking microRNA targets

  2010cited by this paper
• Aptamers as therapeutics

  2010cited by this paper
• Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial.

  2010cited by this paper
• Identifying druggable disease-modifying gene products.

  2009cited by this paper
• Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors

  2009cited by this paper
• A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene.

  2009cited by this paper
• In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses

  2009cited by this paper
• MicroRNAs: Target Recognition and Regulatory Functions

  2009cited by this paper
• Identification of Host Proteins Required for HIV Infection Through a Functional Genomic Screen

  2008cited by this paper
• Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.

  2008cited by this paper
• Profiling Essential Genes in Human Mammary Cells by Multiplex RNAi Screening

  2008cited by this paper
• Cancer Proliferation Gene Discovery Through Functional Genomics

  2008cited by this paper
• CRISPR Interference Limits Horizontal Gene Transfer in Staphylococci by Targeting DNA

  2008cited by this paper
• Systemic Leukocyte-Directed siRNA Delivery Revealing Cyclin D1 as an Anti-Inflammatory Target

  2008cited by this paper
• Antisense inhibition of proprotein convertase subtilisin/kexin type 9 reduces serum LDL in hyperlipidemic mice Published, JLR Papers in Press, January 22, 2007.

  2007cited by this paper
• Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1

  2007cited by this paper
• CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes

  2007cited by this paper
• Activating gene expression in mammalian cells with promoter-targeted duplex RNAs.

  2007cited by this paper
• Small dsRNAs induce transcriptional activation in human cells

  2006cited by this paper
• Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras

  2006cited by this paper
• Position-specific chemical modification of siRNAs reduces "off-target" transcript silencing.

  2006cited by this paper
• Silencing of microRNAs in vivo with ‘antagomirs’

  2005cited by this paper
• Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

  2005cited by this paper
• Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors

  2005cited by this paper
• RNA structure: the long and the short of it

  2005cited by this paper
• Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA

  2005cited by this paper

• The structure and functions of TRAF families and recent advances of TRAFs in leukemia

  2026cites this paper
• Engineering lipid nanoparticles with improved endosomal escape for cytoplasmic delivery of RNA drugs

  2025cites this paper
• Coordination-driven self-assembly of biomolecules and metal ions: Advances in methodology and applications

  2025cites this paper
• A catalyst-free bioorthogonal reaction for malononitrile addition to azodicarboxylates

  2025cites this paper
• Regulatory Roles of Mitochondrial tRNA–Derived Fragments in Cardiovascular Health and Disease

  2025cites this paper
• Aptamers as a new frontier in targeted cancer therapy.

  2025cites this paper
• A narrative review of RNA-binding proteins: Key players in cardiovascular health and disease.

  2025cites this paper
• RNA Alternative Splicing and Polyadenylation and Regulation of the Glomerular Filtration Barrier

  2025cites this paper
• Epitranscriptomic alterations induced by environmental toxins: implications for RNA modifications and disease

  2025cites this paper
• Biological function of RNA-binding proteins in myocardial infarction: a potential emerging therapeutic limelight

  2025cites this paper
• Small Molecules Targeting Non-Coding RNAs Regulating Ferroptosis: New Opportunities in Precision Cancer Therapy

  2025cites this paper
• CRISPR-Cas Systems: A Functional Perspective and Innovations

  2025cites this paper
• Clinical Applications of Oligonucleotides for Cancer Therapy.

  2025cites this paper
• Effect and mechanism of miRNA-144-5p-regulated autophagy in older adults with Sarcopenia

  2025cites this paper
• NuFold: end-to-end approach for RNA tertiary structure prediction with flexible nucleobase center representation

  2025cites this paper
• The use of multiple liquid chromatography methods augmented by phosphorus-31 nuclear magnetic resonance to characterize the diastereomer composition in synthetic oligonucleotides

  2025cites this paper
• RNA-binding proteins in bone pathophysiology

  2024cites this paper
• Co-incubation of Short Amphiphilic Peptides with Dicer Substrate RNAs Results in β-Sheet Fibrils for Enhanced Gene Silencing in Cancer Cells

  2024cites this paper
• Harnessing Computational Approaches for RNA-Targeted Drug Discovery

  2024cites this paper
• Advances in Nucleic Acid Drug Delivery Systems for Liver Cancer Treatment

  2024cites this paper
• RNA-binding protein quaking: a multifunctional regulator in tumour progression

  2024cites this paper
• RNA Binding Proteins: Mechanistic Considerations and Perspectives in Controlling Cardiovascular Diseases.

  2024cites this paper
• Exosome-Mediated Transfer of X-Motif-Tagged Anti-MiR-33a-5p Antagomirs to the Medial Cells of Transduced Rabbit Carotid Arteries

  2024cites this paper
• RNA infrastructure profiling illuminates transcriptome structure in crowded spaces.

  2024cites this paper
• The Biological Mechanisms and Clinical Roles of RNA-Binding Proteins in Cardiovascular Diseases

  2024cites this paper
• Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance

  2024cites this paper
• The splicing factor CCAR1 regulates the Fanconi anemia/BRCA pathway

  2024cites this paper
• MicroRNA as Sepsis Biomarkers: A Comprehensive Review

  2024cites this paper
• Targeting Pediatric Solid Tumors in the New Era of RNA Therapeutics.

  2024cites this paper
• Novel diamine-scaffold based N-acetylgalactosamine (GalNAc)–siRNA conjugate: synthesis and in vivo activities

  2024cites this paper
• Significant downregulation of Alzheimer's amyloid-β levels enabled by engineered DNA nanomaterials

  2024cites this paper
• RNA Control via Redox-Responsive Acylation

  2024cites this paper
• Evaluation of size-exclusion chromatography, multi-angle light scattering detection and mass photometry for the characterization of mRNA.

  2024cites this paper
• Liquid crystalline inverted lipid phases encapsulating siRNA enhance lipid nanoparticle mediated transfection

  2024cites this paper
• Advances in machine-learning approaches to RNA-targeted drug design

  2024cites this paper
• Combination of anti-miR19a-3p polyplex plus doxorubicin for breast cancer in 2D culture and apoptosis assay in 3D spheroids in a microwell device

  2023cites this paper
• An insight of different classes of RNA-based therapeutic, nanodelivery and clinical status: current landscape

  2023cites this paper
• RNA Infrastructure Profiling Illuminates Transcriptome Structure in Crowded Spaces

  2023cites this paper
• NuFold: A Novel Tertiary RNA Structure Prediction Method Using Deep Learning with Flexible Nucleobase Center Representation

  2023influential citation
• Editorial: Host response to veterinary infectious diseases: role of coding and non-coding RNAs as biomarkers and disease modulators

  2023cites this paper
• Genetic Modulation: Future Trends Toward Graft Optimization During Machine Perfusion

  2023cites this paper
• The lncRNA HOTAIR: a pleiotropic regulator of epithelial cell plasticity

  2023cites this paper
• Failure of cartilage regeneration: emerging hypotheses and related therapeutic strategies

  2023cites this paper
• Chemistry, structure and function of approved oligonucleotide therapeutics

  2023influential citation
• Advances in RNA cancer therapeutics: New insight into exosomes as miRNA delivery

  2023cites this paper
• Oligonucleotides Containing C5‐Propynyl Modified Arabinonucleic Acids: Synthesis, Biophysical and Antisense Properties

  2023cites this paper
• The role and regulation of Maf proteins in cancer

  2023cites this paper
• Extracellular Non-Coding RNAs in Cardiovascular Diseases

  2023cites this paper
• Clinical Pharmacokinetics of Approved RNA Therapeutics

  2023cites this paper
• THESIS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY Quantitative NanoSIMS provides subcellular concentration and distribution of oligonucleotide therapeutics

  2023cites this paper
• 2'-OH as a universal handle for studying intracellular RNAs.

  2023cites this paper
• Binding sites of miRNA on the overexpressed genes of oral cancer using 7mer-seed match

  2022cites this paper
• Efficient healing of large osseous segmental defects using optimized chemically modified messenger RNA encoding BMP-2

  2022cites this paper
• Aptamer-Enabled Nanomaterials for Therapeutics, Drug Targeting and Imaging

  2022cites this paper
• Integrated pretraining with evolutionary information to improve RNA secondary structure prediction

  2022cites this paper
• Sequence-specific eDNA extraction using hydrophobic magnetic ionic liquids attached with oligonucleotide strand.

  2022cites this paper
• FOXK2 transcription factor and its roles in tumorigenesis (Review)

  2022cites this paper
• Cholesterol‐conjugated siRNAs silence gene expression in mucosal dendritic cells in cervicovaginal tissue in mice

  2022cites this paper
• Genetically Encoded Light-Up RNA Amplifier Dissecting MicroRNA Activity in Live Cells.

  2022cites this paper
• Rapid identi fi cation of short oligonucleotide impurities using lithium adduct consolidated MALDI-TOF mass spectrometry International Journal of Mass Spectrometry

  2022cites this paper
• RNA therapeutics: updates and future potential

  2022influential citation
• Role of miRNA dysregulation in sepsis

  2022cites this paper
• RNA-Binding Proteins: Emerging Therapeutics for Vascular Dysfunction

  2022cites this paper
• Rapid identification of short oligonucleotide impurities using lithium adduct consolidated MALDI-TOF mass spectrometry

  2022cites this paper
• Chemical Modifications of CRISPR RNAs to Improve Gene-Editing Activity and Specificity.

  2022cites this paper
• LncRNA OGFRP1 promotes angiogenesis and epithelial-mesenchymal transition in colorectal cancer cells through miR-423-5p/CTCF axis.

  2022cites this paper
• Splicing Modulation as a Promising Therapeutic Strategy for Lysosomal Storage Disorders: The Mucopolysaccharidoses Example

  2022cites this paper
• Subcutaneous delivery of FGF21 mRNA therapy reverses obesity, insulin resistance, and hepatic steatosis in diet-induced obese mice

  2022cites this paper
• Multimeric RNAs for efficient RNA-based therapeutics and vaccines

  2022cites this paper
• Structural Fingerprinting of siRNA Therapeutics by Solution NMR Spectroscopy

  2022cites this paper
• Recent Advances in Single-Cell Profiling and Multispecific Therapeutics: Paving the Way for a New Era of Precision Medicine Targeting Cardiac Fibroblasts

  2021cites this paper
• RNAi for livestock improvement

  2021cites this paper
• Topical Application of Peptide-Chondroitin Sulfate Nanoparticles Allows Efficient Photoprotection in Skin.

  2021cites this paper
• The role of m6A, m5C and Ψ RNA modifications in cancer: Novel therapeutic opportunities

  2021cites this paper
• Biochemical features and mutations of key proteins in SARS-CoV-2 and their impacts on RNA therapeutics

  2021cites this paper
• The corepressors GPS2 and SMRT control enhancer and silencer remodeling via eRNA transcription during inflammatory activation of macrophages.

  2021cites this paper
• Emerging role of RNA interference in immune cells engineering and its therapeutic synergism in immunotherapy

  2021cites this paper
• Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown

  2021cites this paper
• The Many Facets of Therapy Resistance and Tumor Recurrence in Glioblastoma

  2021cites this paper
• The Long Non-Coding RNA HOTAIR Is a Critical Epigenetic Mediator of Angiogenesis in Diabetic Retinopathy

  2021cites this paper
• In vivo uptake of antisense oligonucleotide drugs predicted by ab initio quantum mechanical calculations

  2021cites this paper
• Non-Coding RNAs in Cancer Diagnosis and Therapy: Focus on Lung Cancer

  2021cites this paper
• TREX1 as a Novel Immunotherapeutic Target

  2021influential citation
• SHAPE Directed Discovery of New Functions in Large RNAs.

  2021cites this paper
• A novel RNA-based approach to counteract EMT

  2021cites this paper
• Thermostability, Tunability, and Tenacity of RNA as Rubbery Anionic Polymeric Materials in Nanotechnology and Nanomedicine-Specific Cancer Targeting with Undetectable Toxicity.

  2021cites this paper
• RNA Interference and Nanotechnology: A Promising Alliance for Next Generation Cancer Therapeutics

  2021cites this paper
• RNAs - a new frontier in crop protection.

  2021cites this paper
• LncRNA RCAT1 promotes tumor progression and metastasis via miR-214-5p/E2F2 axis in renal cell carcinoma

  2021cites this paper
• Triple negative breast cancer and non-small cell lung cancer: Clinical challenges and nano-formulation approaches.

  2021cites this paper
• Zn2+-Coordination-Driven RNA Assembly with Retained Integrity and Biological Functions.

  2021cites this paper
• Derivation and Progress of Non-enzymatic RNA Replication

  2021cites this paper
• RNA aptamers for AMPA receptors.

  2021cites this paper
• Guanidinium Hydrophobic Magnetic Ionic Liquid-Based Dispersive Droplet Extraction for the Selective Extraction of DNA.

  2021cites this paper
• Membrane‐destabilizing ionizable lipid empowered imaging‐guided siRNA delivery and cancer treatment

  2021cites this paper
• Chemically modified mRNA beyond COVID-19: Potential preventive and therapeutic applications for targeting chronic diseases

  2021cites this paper
• RNA-binding proteins and their role in kidney disease

  2021cites this paper
• Advances in the application of Let-7 microRNAs in the diagnosis, treatment and prognosis of leukemia

  2021cites this paper
• Polymeric nanoparticles for RNA delivery

  2021cites this paper
• Synthetic mRNA - emerging new class of drug for tissue regeneration.

  2021cites this paper